The global breast cancer screening tests industry, valued at USD 2.1 billion in 2023, is set to achieve significant growth, reaching USD 4.4 billion by 2033, according to recent market projections. This robust growth trajectory reflects a CAGR of approximately 7.8% over the forecast period (2023–2033). Globally, digital mammography has supplanted traditional film-based mammography. Digital …